Library
Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers.
8 February 2026. doid: 10.1002/bcp.70459
Neijenhuis LKA, Pesch CMW, Frangioni JV, Vahrmeijer AL, Burggraaf J, Klarenbeek NB
View publicationFluorescence-guided surgery enhances intraoperative visualization of anatomical structures. Nizaracianine is a near-infrared fluorescent agent that is exclusively renally cleared in animal models. It enables real-time ureteral imaging and identification, potentially reduces risk of injury and facilitates assessment before surgical closure. While a single dose has shown to be safe, repeated administration may be necessary during prolonged abdominopelvic procedures.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.